Interchangeability and Physician Notification
Patients and Physicians Want Doctors Involved in Treatment Decisions. ASBM One Pager on Automatic Substitution.
ASBM Statement on Automatic Substitution
As ASBM works with stakeholders to develop an official position statement on automatic substitution, there are a few key principles that ASBM believes must be reflected in any policy recommendation.
National Advisory Board Convene on Physician Notification
ASBM Chairman Dr. Richard Dolinar convened a working group of Advisory Board members on May 24, 2012 to discuss the elements of a physician notification policy for biosimilars that prioritizes patient safety.
ASBM Article on Biosimilars and Interchangeability
Dr. Dolinar wrote an article for May edition of the BIO Newsletter that discusses Interchangeability.
Read Biosimilars Ahead, Proceed with Caution
Read more on state legislation on interchangeability on our Policy Resources page.
Presentation: A Framework to Ensure Safe Substitution
Read the presentation